Micron Biomedical, Inc., a clinical-stage biopharmaceutical innovator, has successfully raised $43 million in funding to advance its groundbreaking proprietary patch technology. This innovative approach revolutionizes the delivery, storage, and distribution of drugs and vaccines, simplifying the administration process for patients and healthcare providers alike. By harnessing this advanced patch technology, Micron aims to increase access to crucial medicinal therapies, particularly for those that traditionally require expert injections. The newly acquired funds will be instrumental in propelling the development of the company鈥檚 product pipeline, which focuses on improving safety and efficacy through skin-targeted delivery. With this funding, Micron Biomedical is well-positioned to accelerate clinical trials and move closer to bringing its transformative solutions to market. The company鈥檚 commitment to enhancing patient outcomes and broadening access to vital healthcare products marks a significant step forward in addressing existing barriers in the biopharmaceutical landscape. As Micron Biomedical takes these important strides, the healthcare community eagerly anticipates the impact of their innovative solutions on patient care and treatment accessibility.
Revolutionizing Drug Delivery: Micron Biomedical Secures $43M in Grant Funding
Recently funded 路 $43.0M GrantBiotechnology
Get the full Micron Biomedical company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Grant rounds
Companies that recently closed a Grant round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Scanalytics Inc. United States | Grant | $1.3M | 1mo ago |
| 2 |  Daylight Solutions United States | Grant | $871.2K | 1mo ago |
.png&w=3840&q=75)
